Mechanistic description
Molecules that specifically sequester or neutralize C9orf72 arginine-rich dipeptide repeat proteins (DPRs) could prevent their disruption of normal TDP-43 phase separation, addressing a major upstream cause of TDP-43 pathology in C9orf72-ALS/FTD.
Debate provenance: derived from debate sess_sda-2026-04-01-gap-006 on question: TDP-43 undergoes liquid-liquid phase separation that becomes pathological. Small molecules targeting phase separation properties could be therapeutic but the design principles are undefined.. Consensus signal: clinical_trialist, domain_expert, medicinal_chemist, skeptic, synthesizer, theorist discussed the mechanism terms ALS/FTD, Agents, C9orf72, DPR, Neutralizing, TDP. Novelty signal: skeptic-discussed-with-qualified-concession.
Evidence for (1)
Evidence matrix
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). C9orf72 DPR Neutralizing Agents. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-debate-6d4773e443b4
@misc{scidex_hypothesis_hdebate6,
title = {C9orf72 DPR Neutralizing Agents},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-debate-6d4773e443b4},
note = {SciDEX artifact hypothesis:h-debate-6d4773e443b4}
}